ChicagoCHEC’s Post

Last year, your gifts supported the brightest minds in oncology, helping them continue to accelerate research for every type of cancer, from the common to the rare. In the process, you made a lifesaving impact in cancer care. Read the 2023 Impact Report today https://brnw.ch/21wIQw4

Check out our recent blog post to learn about next-generation cancer models and how they can support your research. --> https://lnkd.in/emaQu5jv the-human-cancer-models-initiative

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://lnkd.in/gRc_wcPh Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

Want to learn more about the role of RNA in oncology? Tune in to the latest episode of Onc Now to find out, featuring Sarah Blagden CEO of RNA GUARDIAN LTD, who explores the latest breakthroughs in oncology, the future of cancer prevention, and the potential of innovative therapies. Watch here: https://hubs.la/Q02X4h2Y0

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4cyJjEm Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4ewD8CF Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

Dr. Harry Lander, CEO and co-founder of Canary Oncoceutics, shares his thoughts on ISMPO-CON 24 and the role of Canary Oncoceutics in shaping the future of oncology. Watch to learn how they're pushing boundaries in cancer care! #ISMPOCON24 #CanaryOncoceutics #OncologyLeadership

Great discussion with Maggie Shaw at AJMC - The American Journal of Managed Care at #COA2024! The Change Healthcare cyberattack impacted almost every part of our healthcare ecosystem and it will be months before we are “back to normal”. Interesting how many of our session topics: Cybersecurity or Revenue Cycle were so timely.

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/3KWYk7p Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment

Grab a seat and join the conversation as co-host Maria Wilson chats with Louis Vermeulen about the latest breakthroughs in cancer research. They dive into why catching cancer early is so crucial, how personalized treatments are changing outcomes, and the exciting ways #AI and #machinelearning are helping us better diagnose and treat cancer. Our goal is to one day make cancer a condition we can manage long-term. With ongoing research, tailored treatments, and smart use of big data, we’re getting closer each day to making that vision a reality. #TSWIAB